Webinar

Discovery in Litigation
(IP-Sensitive Contexts)

Speakers: Dr. Alka Mehta & Dr. Poonam Raghuvanshi
Date: May 19, 2026
Time: 10:30 AM to 12:30 PM IST

The session will provide practical insights into how discovery unfolds in pharma and IP litigation, and why everyday communications, documents, and regulatory records can become critical evidence during disputes.

Agenda

Key Case Discussions
Discovery – concept, scope, and practical relevance
Importance for IP, R&D, and regulatory teams
How discovery actually happens in litigation
Litigation hold: key do’s and don’ts
Attorney-Client Privilege (ACP) & Work Product concepts
Discovery risks in emails, drafts, and internal communications
Depositions: what to expect and how documents are used
Real pharma/IP case studies and lessons learned
Email communication best practices for litigation-sensitive environments

Our Speakers

Dr. Poonam Raghuvanshi

Dr. Poonam Raghuvanshi has 32+ years of leadership experience across pharmaceutical R&D and intellectual property
M.Pharm and Doctorate in Pharmaceutical Chemistry.
Known for IP strategy development, portfolio management, and cross-functional problem solving across complex pharmaceutical programs.

Dr. Alka Mehta

Dr. Alka Mehta brings over 28 years of experience across pharmaceutical R&D, intellectual property, regulatory affairs, and pharmaceutical law. She holds M. Pharm, a Ph.D. in Pharmaceutics, an LLB, and a Ph.D. in Pharmaceutical Law. Her expertise includes IP risk mitigation, patent and litigation strategy, regulatory-IP interface assessment, and competitive positioning for pharmaceutical products.

The session is designed to provide practical, business-focused guidance with real-world examples from pharmaceutical and IP litigation contexts.

We look forward to your participation.

Scroll to Top